Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYSB2400080	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2024-04-08					view
JYSB2400079	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2024-04-08					view
JXSS2200042	甘精胰岛素注射液	insulin glargine	Injection	Biological Products(3.3)	Import Drug Application	2022-12-27					view
JXSS2200043	甘精胰岛素注射液	insulin glargine	Injection	Biological Products(3.3)	Import Drug Application	2022-12-27					view
JXSS2000065	甘精胰岛素注射液	insulin glargine	Injection	Biological Products(3.3)	Import Drug Application	2020-12-23	礼来苏州制药有限公司	Lilly Suzhou Pharmaceutical Co Ltd	In Review	2020-12-22	view
JXSS2000064	甘精胰岛素注射液	insulin glargine	Injection	Biological Products(3.3)	Import Drug Application	2020-12-23	礼来苏州制药有限公司	Lilly Suzhou Pharmaceutical Co Ltd	In Review	2021-05-09	view
JYSB2000180	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2020-05-20	Eli Lilly Regional Operations GmbH	Eli Lilly Regional Operations GmbH	In Review	2020-05-19	view
JYSB2000181	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2020-05-20	Eli Lilly Regional Operations GmbH	Eli Lilly Regional Operations GmbH	In Review	2020-05-19	view
JXSL1500016	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Import Drug Application	2015-05-09	Eli Lilly Regional Operations GmbH	Eli Lilly Regional Operations GmbH	Certificate Issued	2017-06-19	view
JXSL1500017	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Import Drug Application	2015-04-24	Eli Lilly Regional Operations GmbH	Eli Lilly Regional Operations GmbH	Certificate Issued	2017-06-19	view
JXSL1100041	LY2963016(BIV)注射液	insulin glargine	Injection	Biological Products	Import Drug Application	2011-09-29	Eli Lilly and Company	Eli Lilly & Company	Certificate Issued	2015-04-09	view
JXSL1100042	LY2963016(BIV)注射液	insulin glargine	Injection	Biological Products	Import Drug Application	2011-09-23	Eli Lilly and Company	Eli Lilly & Company	Certificate Issued	2015-04-09	view